Literature DB >> 31678252

Osteogenic gene markers are epigenetically reprogrammed during contractile-to-calcifying vascular smooth muscle cell phenotype transition.

Rodrigo A da Silva1, Geórgia da S Feltran2, Célio Júnior da C Fernandes2, Willian F Zambuzzi3.   

Abstract

The understanding of vascular calcification-based mechanism is an urgent pending task in vascular biology and this prompted us to better address this issue by investigating whether DNA methylation mechanism might drive osteogenic marker genes modulation in primary human vascular smooth muscle cells (VSMCs) responding to calcium and phosphate levels overload up to 72 h. Firstly, our data shows this calcifying process recapitulates the molecular repertory of osteogenic biomarkers and specifically requiring RUNX2, Osterix and ALP, BSP genes activations along 72 h in vitro, and this behavior was validated here using other lineages. Conversely, both BMPs 4 and 7 were significantly overexpressed, maybe already as a mechanism in response to RUNX2 and Osterix genes activities identified earlier in response to the calcifying condition, and taken into maintain the calcifying phenotype of VSMCs. Additionally, survival signaling was maintained active and accompanied by a dynamic cytoskeleton rearrangement signaling requiring MAPK and AKT phosphorylations. Moreover, during the contractile-to-calcifying transition phenotype of VSMCs, epigenetic machinery was finely modulated, requiring the translocation of DNMT3B and TET2 into nucleus and this prompted us evaluating whether the profile of osteogenic-related gene promoters' methylation might contribute with this process. By firstly estimating 5meC/5 hmeC ratio changes, we further specifically show the significance of the epigenetic modulation of Osterix and Bone sialoprotein related gene promoters, presenting a positive correlation between the epigenetic signature of their gene promoters and transcriptional patterns. Altogether, our results show for the first time the importance of epigenetic mechanism on modulating osteogenic gene markers reprogramming during calcifying VSMCs phenotype acquisition, which might drive the genesis of vascular ectopic calcification.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; DNA methylation; Osteogenic phenotypic acquisition; Vascular smooth muscle cells; Vessel calcification

Year:  2019        PMID: 31678252     DOI: 10.1016/j.cellsig.2019.109458

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  3 in total

1.  Cystatin-like protein of sweet orange (CsinCPI-2) modulates pre-osteoblast differentiation via β-Catenin involvement.

Authors:  Willian Fernando Zambuzzi; Gisele Faria; Célio da Costa Fernandes; Victor Manuel Ochoa Rodríguez; Andrea Soares-Costa; Joni Augusto Cirelli; Daniela Morilha Neo Justino; Bárbara Roma
Journal:  J Mater Sci Mater Med       Date:  2021-03-22       Impact factor: 3.896

Review 2.  Inflammation: a putative link between phosphate metabolism and cardiovascular disease.

Authors:  Jakob Voelkl; Daniela Egli-Spichtig; Ioana Alesutan; Carsten A Wagner
Journal:  Clin Sci (Lond)       Date:  2021-01-15       Impact factor: 6.124

Review 3.  Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification.

Authors:  Duk-Hwa Kwon; Juhee Ryu; Young-Kook Kim; Hyun Kook
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.